ICMJE Recommendations 2026 update: what’s new?
All you need to know about the 2026 update to the ICMJE Recommendations.
Wiley develops AI guidelines in response to demand from researchers
Find out more about the guidelines aiming to embrace use of AI, ethically.
Why aren’t more journals publishing plain language summaries?
A recent survey sheds light on publisher perspectives on plain language summaries and the barriers to their wider adoption.
Are conflicts of interest reported transparently in healthcare guidelines?
Discover the RIGHT-COI&F checklist, developed to improve conflict of interest and funding reporting in healthcare guidelines.
Publisher policies on AI use: is it time for change?
Find out how publisher AI policies need to evolve in the face of fast-changing technology.
Overcoming bias in ”˜overviews of reviews’: a spotlight on appraisal tools
Planning to write an overview of systematic reviews? Uncover essential guidance on the effective use of tools to assess and minimise bias.
ICMJE recommendations update 2024: what’s new and what’s next?
All you need to know about the latest updates to the ICMJE recommendations.
SPIRIT-Outcomes 2022 Extension: guidelines for transparent inclusion of clinical trial outcomes in trial protocols
How to improve outcome reporting in clinical trial protocols: read more about the SPIRIT-Outcomes 2022 Extension.
CONSORT-Outcomes 2022 Extension: guidelines for complete reporting of clinical trial outcomes
The 17 items to include when reporting clinical trial outcomes. Read about the CONSORT-Outcomes 2022 Extension checklist for outcomes of all randomised clinical trials.
To tweet or not to tweet: social media guidance to help pharmaceutical companies adhere to the ABPI Code of Practice
Read about new guidance from the PMCPA that aims to ensure the social media activities of pharmaceutical companies stay within the law.